Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The good, the bad and the ugly: rectal cancers in the twenty-first century.

Literature DB >> 28631136

The good, the bad and the ugly: rectal cancers in the twenty-first century.

G P São Julião¹, A Habr-Gama¹, B B Vailati¹, R O Perez^2,3,4.

Abstract

Entities: Disease

Mesh：

Year: 2017 PMID： 28631136 DOI： 10.1007/s10151-017-1651-7

Source DB: PubMed Journal: Tech Coloproctol ISSN： 1123-6337 Impact factor: 3.781

× No keyword cloud information.

28 in total

1. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors: E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal: N Engl J Med Date: 2001-08-30 Impact factor: 91.245

2. Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors: B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal: N Engl J Med Date: 1997-04-03 Impact factor: 91.245

3. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial.

Authors: Julio Garcia-Aguilar; Oliver S Chow; David D Smith; Jorge E Marcet; Peter A Cataldo; Madhulika G Varma; Anjali S Kumar; Samuel Oommen; Theodore Coutsoftides; Steven R Hunt; Michael J Stamos; Charles A Ternent; Daniel O Herzig; Alessandro Fichera; Blase N Polite; David W Dietz; Sujata Patil; Karin Avila
Journal: Lancet Oncol Date: 2015-07-14 Impact factor: 41.316

4. Baseline T Classification Predicts Early Tumor Regrowth After Nonoperative Management in Distal Rectal Cancer After Extended Neoadjuvant Chemoradiation and Initial Complete Clinical Response.

Authors: Angelita Habr-Gama; Guilherme Pagin São Julião; Joaquim Gama-Rodrigues; Bruna Borba Vailati; Cinthia Ortega; Laura Melina Fernandez; Sérgio Eduardo Alonso Araújo; Rodrigo Oliva Perez
Journal: Dis Colon Rectum Date: 2017-06 Impact factor: 4.585

5. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors: Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal: J Clin Oncol Date: 2012-04-23 Impact factor: 44.544

Review 6. Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.

Authors: Joseph C Kong; Glen R Guerra; Satish K Warrier; Robert G Ramsay; Alexander G Heriot
Journal: Dis Colon Rectum Date: 2017-03 Impact factor: 4.585

7. Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal Cancer.

Authors: Milou H Martens; Monique Maas; Luc A Heijnen; Doenja M J Lambregts; Jeroen W A Leijtens; Laurents P S Stassen; Stephanie O Breukink; Christiaan Hoff; Eric J Belgers; Jarno Melenhorst; Rob Jansen; Jeroen Buijsen; Ton G M Hoofwijk; Regina G H Beets-Tan; Geerard L Beets
Journal: J Natl Cancer Inst Date: 2016-08-10 Impact factor: 13.506

Review 8. Effect of preoperative radio(chemo)therapy on long-term functional outcome in rectal cancer patients: a systematic review and meta-analysis.

Authors: Martin Loos; Philipp Quentmeier; Tibor Schuster; Ulrich Nitsche; Ralf Gertler; Andreas Keerl; Thomas Kocher; Helmut Friess; Robert Rosenberg
Journal: Ann Surg Oncol Date: 2012-12-27 Impact factor: 5.344

9. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.

Authors: Julio Garcia-Aguilar; Lindsay A Renfro; Oliver S Chow; Qian Shi; Xiomara W Carrero; Patricio B Lynn; Charles R Thomas; Emily Chan; Peter A Cataldo; Jorge E Marcet; David S Medich; Craig S Johnson; Samuel C Oommen; Bruce G Wolff; Alessio Pigazzi; Shane M McNevin; Roger K Pons; Ronald Bleday
Journal: Lancet Oncol Date: 2015-10-22 Impact factor: 41.316

10. Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen.

Authors: Angelita Habr-Gama; Rodrigo O Perez; Guilherme P São Julião; Igor Proscurshim; Laura M Fernandez; Marleny N Figueiredo; Joaquim Gama-Rodrigues; Carlos A Buchpiguel
Journal: Radiat Oncol Date: 2016-02-24 Impact factor: 3.481

5 in total

Review 4. Role of magnetic resonance imaging in organ-preserving strategies for the management of patients with rectal cancer.

Authors: Cinthia D Ortega; Rodrigo O Perez
Journal: Insights Imaging Date: 2019-05-30

5. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.

Authors: T Akiyoshi; S Toda; T Tominaga; K Oba; K Tomizawa; Y Hanaoka; T Nagasaki; T Konishi; S Matoba; Y Fukunaga; M Ueno; H Kuroyanagi
Journal: BJS Open Date: 2019-07-25